top of page

1 min read

VBI-S for the Treatment of Hypotension in Hypovolemic Septic Shock Patients

See Trial Information here: https://clinicaltrials.gov/study/NCT04257136?tab=table

Recent Posts

Selective nitric oxide redistribution by phospholipid nanoparticles: A novel strategy to mitigate massive nitric oxide release and prevent reperfusion injury in septic shock

Vivacelle Bio Commemorates Sepsis Awareness Month, Recognizing the Leading Cause of Death in U.S. Hospitals

Treating Septic Shock with Nanoparticle Formulation that Redistributes Nitric Oxide with Dr. Harven DeShield - Vivacelle Bio on the Empowered Patient Podcast with Karen Jagoda

Comments

bottom of page